Smith Group Asset Management’s Usana Health Sciences USNA Stock Holding History

Smith Group Asset Management’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-3,460	Closed	-$290K	–	461
2019 Q1	$290K	Sell	3,460 -11,520	-77%	-$1.2M	0.01%	202
2018 Q4	$1.76M	Buy	14,980 +6,380	+74%	+$738K	0.06%	140
2018 Q3	$1.04M	Buy	+8,600	New	+$1.07M	0.03%	170
2016 Q1	–	Sell	-36,340	Closed	-$2.32M	–	526
2015 Q4	$2.32M	Sell	36,340 -6,020	-14%	-$390K	0.07%	136
2015 Q3	$2.84M	Buy	42,360 +28,720	+211%	+$2.03M	0.11%	127
2015 Q2	$932K	Buy	13,640 +380	+3%	+$24.1K	0.03%	171
2015 Q1	$737K	Sell	13,260 -1,000	-7%	-$51.3K	0.02%	187
2014 Q4	$731K	Buy	+14,260	New	+$700K	0.03%	193
2014 Q2	–	Sell	-109,388	Closed	-$4.12M	–	447
2014 Q1	$4.12M	Buy	109,388 +108,890	+21,865%	+$3.8M	0.16%	114
2013 Q4	$18K	Sell	498 -69,726	-99%	-$2.67M	﹤0.01%	286
2013 Q3	$3.05M	Sell	70,224 -7,242	-9%	-$291K	0.13%	134
2013 Q2	$2.8M	Buy	+77,466	New	+$2.35M	0.12%	144

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JIM

Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Smith Group Asset Management's USNA Position: Q2 2019 in Review

Smith Group Asset Management sold out of Usana Health Sciences (USNA) in Q2 2019, closing a stake of 3,460 shares — an estimated $290K sold.

Smith Group Asset Management first reported a position in USNA in Q2 2013 and held it in 12 quarters. The position peaked at $4.12M in Q1 2014. 173 funds tracked by Wall St. Rank hold USNA as of Q2 2019.

Smith Group Asset Management reported no remaining Usana Health Sciences position as of Q2 2019 after selling out during the quarter.
Smith Group Asset Management sold 3,460 Usana Health Sciences shares in Q2 2019, an estimated $290K.
Smith Group Asset Management first reported a position in Usana Health Sciences in Q2 2013 and held it in 12 quarters.
Smith Group Asset Management's Usana Health Sciences position peaked at $4.12M in Q1 2014.
173 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2019.

Based on Smith Group Asset Management's 13F filing for Q2 2019, filed 8 Aug 2019.